PLENARY SESSION: A DEEP DIVE INTO THE FUTURE OF ADVANCED THERAPIES

Aseptic Technologies Ballroom

This session will feature leading executives in the advanced therapies space who will discuss a number of topics including the current state of the sector, future technologies and innovations, and a forecast on potential approvals. The session will also touch upon solutions for manufacturing and regulatory bottlenecks as the sector moves towards commercialization, as well as the evolution of reimbursement payment models.

Moderator:

Anshul Mangal, President, Project Farma and Precision ADVANCE – Confirmed

Speakers:

Phil Cyr, Senior Vice President, Precision Value & Health – Confirmed

Derek Hicks, Chief Business Officer, Intellia Therapeutics – Confirmed

Ann Lee, Ph.D., Chief Technical Officer, Prime Medicine – Confirmed

Bob Smith, Senior Vice President, Global Gene Therapy Business, Pfizer – Confirmed

Arthur Tzianabos, Ph.D., Venture Partner, 5AM Ventures – Confirmed

Event Timeslots (1)

Tuesday | October 10, 2023
-
brady brady



By using this website you agree to accept our Privacy Policy and Terms & Conditions